Abstract
We have not added the abstract for this paper yet. The publisher's page has the full record.
A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study
Alzheimer's & Dementia · Vol. 16, pp. 1412-1425 Published January 1, 2020
More on these topics
Browse all publications →-
2021 · Alzheimer's & Dementia
Complementary analyses of the AMBAR trial: Individual items of CDR and ADAS-Cog12 in Alzheimer's disease patients treated with plasma exchange with albumin replacement
-
2020 · Alzheimer's & Dementia
Complementary analyses of the AMBAR trial: Impact of discontinuations, consistency of results across outcomes and additional adjustments
-
2026 · Alzheimers Dement.
Evaluating digital cognitive tests for clinical use in Alzheimer's disease: A novel framework and scoping review
-
2026 · Stat Med.
Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive Diseases